Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +15.00%
#4 Fabric Protocol Fabric Protocol +11.98%
#5 Bedrock Bedrock +8.56%
#6 Perle Perle +7.51%
#7 BOOK OF MEME BOOK OF MEME +4.97%
#8 Cap Cap +4.16%
#9 Centrifuge Centrifuge +3.80%
#10 Acurast Acurast +3.64%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Rangering i aksjer #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Aksjekurs
$0.1
Sist synkronisert: 2024-06-18
Markedsverdi
$1.31M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Pascal Biosciences Inc. (PSCBF)

Kategori

Healthcare
Inntekter for Pascal Biosciences Inc. (PSCBF)
Inntekter i Feb 2024 TTM: $700.83K
Ifølge de nyeste økonomiske rapportene til Pascal Biosciences Inc. er selskapets nåværende inntekter (TTM) $700.83K. I 2022 hadde selskapet inntekter på 0.00 lik inntektene i 2021, som var 0.00. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Pascal Biosciences Inc. fra 2019 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $700.83K 41.81%
2023 $494.20K 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 1,801,231.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 859,063.16%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 1,442,584.10%
BE